MYLAN N.V.
`
`FORM 8-K
`
`(Current report filing)
`
`Filed 06/19/15 for the Period Ending 06/19/15
`
`
`Telephone
`CIK
`SIC Code
`Fiscal Year
`
`
`44 0 1707 853 000
`0001623613
`2834 - Pharmaceutical Preparations
`12/31
`
`http://www.edgar-online.com
`© Copyright 2015, EDGAR Online, Inc. All Rights Reserved.
`Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.
`
`NCI Exhibit 2005
`Page 1 of 4
`
`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`UNITED STATES
`SECURITIES AND EXCHANGE COMMISSION
`WASHINGTON, D.C. 20549
`
`
`FORM 8-K
`
`
`
`CURRENT REPORT
`Pursuant to Section 13 or 15(d)
`of the Securities Exchange Act of 1934
`
`Date of Report (Date of Earliest Event Reported): June 19, 2015
`
`
`
`Mylan N.V.
`
`(Exact name of registrant as specified in its charter)
`
`The Netherlands
`(State or other jurisdiction
`of incorporation)
`
`
`
`
`
`
`
`333-199861
`(Commission
`File Number)
`
`
`
`
`
`98-1189497
`(IRS Employer
`Identification No.)
`
`Building 4, Trident Place
`Mosquito Way, Hatfield, Hertfordshire
`(Address of principal executive offices)
`
`
`
`
`
`AL10 9UL
`(Zip Code)
`
`+44 (0) 1707 853 000
`(Registrant’s telephone number, including area code)
`
`
`
`Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of
`the following provisions:
`
` Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
`
` Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
`
` Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
`
` Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
`
`
`
`NCI Exhibit 2005
`Page 2 of 4
`
`

`
`Item 1.01. Entry into a Material Definitive Agreement.
`
`Amendment to Senior Revolving Credit Agreement
`
`On June 19, 2015, Mylan N.V. (the “Company”) entered into an additional credit extension amendment (the “Amendment”) among the
`Company, Mylan Inc. (the “Borrower”), ING Bank N.V., Dublin Branch (the “Augmenting Lender”), certain issuing banks and Bank of
`America, N.A., as administrative agent (in such capacity, the “Administrative Agent”), to the Revolving Credit Agreement dated as of
`December 19, 2014, among the Company, the Borrower, the lenders and issuing banks party thereto and the Administrative Agent, as amended
`by Amendment No. 1 to the Revolving Credit Agreement dated as of May 1, 2015 (as amended, the “Credit Agreement”).
`
`The Amendment provides that the Augmenting Lender will make available $150,000,000 of additional revolving commitments under the
`Credit Agreement (such amount, the “Increased Commitments”), increasing the aggregate principal amount of the revolving commitments
`available under the Credit Agreement from $1,500,000,000 to $1,650,000,000. No other changes to the terms of the Credit Agreement were
`effected in connection with the Amendment. Proceeds from the Increased Commitments will be used for working capital, capital expenditures
`and other lawful corporate purposes.
`
`A summary of the terms and conditions of the Revolving Credit Agreement dated as of December 19, 2014 is available in the Borrower’s
`Form 8-K filed with the Securities Exchange Commission (the “SEC”) on December 29, 2014. A summary of the terms and conditions of
`Amendment No. 1 to the Revolving Credit Agreement dated as of May 1, 2015 is available in the Company’s Form 8-K filed with the SEC on
`May 7, 2015.
`
`Certain lenders under the Credit Agreement have, from time to time, performed, are currently performing and may in the future perform,
`various financial advisory and commercial and investment banking services for the Company, for which they received or will receive
`customary fees and expenses.
`
`Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
`
`The disclosure set forth under Item 1.01 above is incorporated by reference into this Item 2.03.
`
`NCI Exhibit 2005
`Page 3 of 4
`
`

`
`Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
`behalf by the undersigned hereunto duly authorized.
`
`
`SIGNATURE
`
`Date: June 19, 2015
`
`MYLAN N.V.
`
`By: /s/ John D. Sheehan
`John D. Sheehan
`Executive Vice President and Chief Financial Officer
`
`NCI Exhibit 2005
`Page 4 of 4